Literature DB >> 16052628

Differences among techniques for high-abundant protein depletion.

Nina Zolotarjova1, James Martosella, Gordon Nicol, Jerome Bailey, Barry E Boyes, William C Barrett.   

Abstract

The need to identify protein or peptide biomarkers via readily available biological samples like serum, plasma, or cerebrospinal fluid is often hindered by a few particular proteins present at relatively high concentrations. The ability to remove these proteins specifically, reproducibly, and with high selectivity is increasingly important in proteomic studies, and success in this procedure is leading to an ever-increasing list of lower abundant proteins being identified in these biological fluids. The current work addresses some of the potential problems in depleting proteins in typical biomarker studies, including nonspecific binding during depletion procedures and whether low molecular weight (LMW) species bind to the column in a so-called "sponge" effect caused by the ability of albumin or other high-abundant proteins to bind peptides or protein fragments. LC-MS/MS methods were applied to the comparative analysis of an IgG-based immunodepletion method and a Cibacron blue (CB)-dye-based method, for specificity of removing targeted proteins (binding fraction), as well as for assessing efficiency of target removal. This analysis was extended to examine the effects of repeated use of materials (cycles of binding and elution), in order to assess potential for carryover of one sample to the next. Capacity studies and efficiency of protein removal from the serum samples were followed for the IgG-based system using both immunochemical assays (ELISA) as well as LC-MS/MS methods. Additionally, the IgG-based system was further characterized for the removal of LMW polypeptides by nonspecific binding. We conclude that the IgG-based system provided effective removal of targeted proteins, with minimal carryover, high longevity, and minimal nonspecific binding. Significant differences are noted between the depletion techniques employed, and this should be considered based on the expectations set during experimental design.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16052628     DOI: 10.1002/pmic.200402021

Source DB:  PubMed          Journal:  Proteomics        ISSN: 1615-9853            Impact factor:   3.984


  65 in total

1.  One-step sample concentration, purification, and albumin depletion method for urinary proteomics.

Authors:  Ali R Vaezzadeh; Andrew C Briscoe; Hanno Steen; Richard S Lee
Journal:  J Proteome Res       Date:  2010-10-15       Impact factor: 4.466

Review 2.  The application of mass-spectrometry-based protein biomarker discovery to theragnostics.

Authors:  Jonathan M Street; James W Dear
Journal:  Br J Clin Pharmacol       Date:  2010-04       Impact factor: 4.335

3.  A proteomic approach for plasma biomarker discovery with 8-plex iTRAQ labeling and SCX-LC-MS/MS.

Authors:  Haige Ye; Li Sun; Xiaojun Huang; Ping Zhang; Xiaoshu Zhao
Journal:  Mol Cell Biochem       Date:  2010-06-05       Impact factor: 3.396

4.  Supramolecular Polymeric Assemblies for the Selective Depletion of Abundant Acidic Proteins in Serum.

Authors:  Mahalia A C Serrano; Jingjing Gao; Katrina A Kelly; S Thayumanavan; Richard W Vachet
Journal:  ACS Appl Mater Interfaces       Date:  2018-11-15       Impact factor: 9.229

Review 5.  Advances and challenges in liquid chromatography-mass spectrometry-based proteomics profiling for clinical applications.

Authors:  Wei-Jun Qian; Jon M Jacobs; Tao Liu; David G Camp; Richard D Smith
Journal:  Mol Cell Proteomics       Date:  2006-08-03       Impact factor: 5.911

6.  Evaluation of multiprotein immunoaffinity subtraction for plasma proteomics and candidate biomarker discovery using mass spectrometry.

Authors:  Tao Liu; Wei-Jun Qian; Heather M Mottaz; Marina A Gritsenko; Angela D Norbeck; Ronald J Moore; Samuel O Purvine; David G Camp; Richard D Smith
Journal:  Mol Cell Proteomics       Date:  2006-07-19       Impact factor: 5.911

7.  Smart hydrogel particles: biomarker harvesting: one-step affinity purification, size exclusion, and protection against degradation.

Authors:  Alessandra Luchini; David H Geho; Barney Bishop; Duy Tran; Cassandra Xia; Robert L Dufour; Clinton D Jones; Virginia Espina; Alexis Patanarut; Weidong Zhou; Mark M Ross; Alessandra Tessitore; Emanuel F Petricoin; Lance A Liotta
Journal:  Nano Lett       Date:  2007-12-13       Impact factor: 11.189

8.  Enhanced detection of low abundance human plasma proteins using a tandem IgY12-SuperMix immunoaffinity separation strategy.

Authors:  Wei-Jun Qian; David T Kaleta; Brianne O Petritis; Hongliang Jiang; Tao Liu; Xu Zhang; Heather M Mottaz; Susan M Varnum; David G Camp; Lei Huang; Xiangming Fang; Wei-Wei Zhang; Richard D Smith
Journal:  Mol Cell Proteomics       Date:  2008-07-15       Impact factor: 5.911

9.  Assessment of albumin removal from an immunoaffinity spin column: critical implications for proteomic examination of the albuminome and albumin-depleted samples.

Authors:  Rebekah L Gundry; Melanie Y White; Julie Nogee; Irina Tchernyshyov; Jennifer E Van Eyk
Journal:  Proteomics       Date:  2009-04       Impact factor: 3.984

10.  The development of an integrated platform to identify breast cancer glycoproteome changes in human serum.

Authors:  Zhi Zeng; Marina Hincapie; Brian B Haab; Samir Hanash; Sharon J Pitteri; Steven Kluck; Jason M Hogan; Jacob Kennedy; William S Hancock
Journal:  J Chromatogr A       Date:  2009-09-16       Impact factor: 4.759

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.